283 related articles for article (PubMed ID: 18852066)
1. Drug discovery: past, present and future.
Malik NN
Drug Discov Today; 2008 Nov; 13(21-22):909-12. PubMed ID: 18852066
[No Abstract] [Full Text] [Related]
2. Merck moves into biotech.
Kling J
Nat Biotechnol; 2006 Jul; 24(7):730. PubMed ID: 16841041
[No Abstract] [Full Text] [Related]
3. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
4. Rational optimization of proteins as drugs: a new era of 'medicinal biology'.
Szymkowski DE
Drug Discov Today; 2004 May; 9(9):381-3. PubMed ID: 15081952
[No Abstract] [Full Text] [Related]
5. The carbohydrate-based drug industry.
Persidis A
Nat Biotechnol; 1997 May; 15(5):479-80. PubMed ID: 9131631
[No Abstract] [Full Text] [Related]
6. Evolution and future of biopharmaceuticals.
Health Aff (Millwood); 2006; 25(5):1270. PubMed ID: 16966722
[No Abstract] [Full Text] [Related]
7. Pharmacogenetics--pivotal to the future of the biopharmaceutical industry.
Foot E; Kleyn D; Palmer Foster E
Drug Discov Today; 2010 May; 15(9-10):325-7. PubMed ID: 20298799
[No Abstract] [Full Text] [Related]
8. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
9. A rollercoaster ride.
Jacobs T
Nat Biotechnol; 2006 Mar; 24(3):284. PubMed ID: 16525390
[No Abstract] [Full Text] [Related]
10. R&D deals boom in 2004.
Lawrence S
Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
[No Abstract] [Full Text] [Related]
11. Developmental biology's impact on drug development.
Cohen CM; Platika D; Scangos G; Kilian P
Nat Biotechnol; 1998 Jul; 16(7):628-31. PubMed ID: 9661194
[No Abstract] [Full Text] [Related]
12. New drugs and changing disease paradigms.
Crooke ST
Nat Biotechnol; 1996 Mar; 14(3):238-41. PubMed ID: 9630876
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness data on biologics needed.
Sheridan C; Katsnelson A
Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069
[No Abstract] [Full Text] [Related]
14. Biotech drugs come of age; policymakers take notice.
Iglehart JK
Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
[No Abstract] [Full Text] [Related]
15. Impact of the human genome on the discovery of immune-modulatory therapeutics.
Manning AM
Curr Opin Investig Drugs; 2006 May; 7(5):406-11. PubMed ID: 16729715
[No Abstract] [Full Text] [Related]
16. 'Shake-up' in drug industry predicted. Interview by Bob Carlson.
Watanabe A
Indiana Med; 1993; 86(4):288-95. PubMed ID: 8366277
[No Abstract] [Full Text] [Related]
17. Drug discovery and development in the age of molecular medicine.
Vallance P; Levick M
Clin Pharmacol Ther; 2007 Oct; 82(4):363-6. PubMed ID: 17851574
[TBL] [Abstract][Full Text] [Related]
18. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
Närhi M; Nordström K
Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
[TBL] [Abstract][Full Text] [Related]
19. Pharmas partner in venture seeking drug discovery tools.
Mack GS
Nat Biotechnol; 2008 Sep; 26(9):960-1. PubMed ID: 18779790
[No Abstract] [Full Text] [Related]
20. New directions in diagnostics.
Med Device Technol; 2000 Oct; 11(8):33. PubMed ID: 11185187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
